You just read:

Arbor Pharmaceuticals Announces FDA Filing Acceptance of New Drug Application (NDA) for AR19, an Investigational ADHD Prescription Stimulant Treatment Specifically Designed to Resist Physical Manipulation for Nonmedical Misuse or Abuse

News provided by

Arbor Pharmaceuticals, LLC

May 13, 2020, 08:55 ET